Literature DB >> 7728346

Mucin-secreting tumors of the pancreas.

D R Lichtenstein1, D L Carr-Locke.   

Abstract

Mucinous pancreatic neoplasms present diagnostic and therapeutic challenges. These tumors behave in an indolent nature, with frequent overlap of symptoms and radiographic appearance with other forms of pancreatic cysts, pseudocysts, and malignancy. Some authors propose that all mucin-producing tumors of the pancreas are variants of the same basic entity and have subclassified them on the basis of their predominant location within the pancreas. These disorders must be considered in the evaluation of chronic abdominal pain, particularly in the presence of a cystic pancreatic lesion or when associated with idiopathic chronic or acute recurrent pancreatitis. The clinicopathologic features of IMHN overlap to a great extent with classic mucinous cystic neoplasms but are different significantly enough to be distinct clinical entities. These tumors originate from the pancreatic duct epithelium, produce mucin, demonstrate a papillary growth pattern, and are considered premalignant or frankly malignant at the time of diagnosis. Both lesions biologically are much less aggressive than that of pancreatic ductal adenocarcinoma and appear to infiltrate peripancreatic tissue and to metastasize to lymph nodes or other adjacent structures late in the course of disease. Nevertheless, IMHNs are located primarily in the head of the pancreas, commonly affect elderly men, and present clinically with obstructive pancreatitis, often leading to pancreatic insufficiency, whereas mucinous cystic neoplasms are more likely to develop in the pancreatic body or tail, predominate in young women, and present with symptoms referable to tumor compression of adjacent structures. The location of the lesion is the primary differentiating feature because the lining epithelium of the two tumor types is indistinguishable pathologically. In mucinous cystic tumors, the mucus is secreted and retained within the cyst lumen because of the absence of communication between the cyst and the main pancreatic duct. In contrast, mucus produced in MDE flows into the main pancreatic duct, resulting in obstructive pancreatitis and, ultimately, dilatation of the pancreatic duct. Intraductal mucus provides an important clue to the diagnosis of intraductal pancreatic neoplasms and, whenever present, should prompt an aggressive diagnostic evaluation. Both lesions are managed by resectional surgery because the opportunity for cure is high in the absence of metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728346

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  8 in total

1.  Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity.

Authors:  J A Rivera; C Fernández-del Castillo; M Pins; C C Compton; K B Lewandrowski; D W Rattner; A L Warshaw
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

Review 2.  [Cystic lesions of the pancreas].

Authors:  U Rosien; P Layer
Journal:  Med Klin (Munich)       Date:  1999-07-15

3.  Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies.

Authors:  Jeanine M Genkinger; Ruifeng Li; Donna Spiegelman; Kristin E Anderson; Demetrius Albanes; Leif Bergkvist; Leslie Bernstein; Amanda Black; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; R Alexandra Goldbohm; Pamela L Horn-Ross; Eric J Jacobs; Anita Koushik; Satu Männistö; James R Marshall; Anthony B Miller; Alpa V Patel; Kim Robien; Thomas E Rohan; Catherine Schairer; Rachael Stolzenberg-Solomon; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-22       Impact factor: 4.254

4.  A Rare Case of an Intraductal Papillary Mucinous Neoplasm of Pancreas Fistulizing Into Duodenum With Adult Polycystic Kidney Disease.

Authors:  Nirav Pipaliya; Chetan Rathi; Pathik Parikh; Ruchir Patel; Meghraj Ingle; Prabha Sawant
Journal:  Gastroenterology Res       Date:  2015-04-03

Review 5.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

6.  Total pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: the treatment of choice.

Authors:  J Bendix Holme; N O Jacobsen; M Rokkjaer; A Kruse
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

7.  Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.

Authors:  Jeanine M Genkinger; Donna Spiegelman; Kristin E Anderson; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; Susan E Hankinson; Pamela L Horn-Ross; Michael Leitzmann; Satu Männistö; James R Marshall; Marjorie L McCullough; Anthony B Miller; Douglas J Reding; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Victoria L Stevens; Rachael Z Stolzenberg-Solomon; Bas A J Verhage; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254

8.  Multifocal intraductal papillary mucinous neoplasm of the pancreas--a case report.

Authors:  Kun-Chun Chiang; Jun Te Hsu; Huang-Yang Chen; Shyh Chuan Jwo; Tsann-Long Hwang; Yi Yin Jan; Chun-Nan Yeh
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.